- Home
- ELVN vs XPEL Comparison
ELVN vs XPEL Comparison
Compare ELVN & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- XPEL
- Stock Information
- Founded
- ELVN 2016
- XPEL 1999
- Country
- ELVN United States
- XPEL United States
- Employees
- ELVN N/A
- XPEL N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- XPEL Industrial Specialties
- Sector
- ELVN Health Care
- XPEL Industrials
- Exchange
- ELVN Nasdaq
- XPEL Nasdaq
- Market Cap
- ELVN 927.8M
- XPEL 991.5M
- IPO Year
- ELVN 2020
- XPEL N/A
- Fundamental
- Price
- ELVN $21.30
- XPEL $36.15
- Analyst Decision
- ELVN Strong Buy
- XPEL Strong Buy
- Analyst Count
- ELVN 5
- XPEL 1
- Target Price
- ELVN $39.60
- XPEL $58.00
- AVG Volume (30 Days)
- ELVN 594.3K
- XPEL 140.7K
- Earning Date
- ELVN 08-12-2025
- XPEL 08-07-2025
- Dividend Yield
- ELVN N/A
- XPEL N/A
- EPS Growth
- ELVN N/A
- XPEL N/A
- EPS
- ELVN N/A
- XPEL 1.71
- Revenue
- ELVN N/A
- XPEL $434,101,000.00
- Revenue This Year
- ELVN N/A
- XPEL $11.20
- Revenue Next Year
- ELVN N/A
- XPEL $11.18
- P/E Ratio
- ELVN N/A
- XPEL $20.86
- Revenue Growth
- ELVN N/A
- XPEL 8.38
- 52 Week Low
- ELVN $13.30
- XPEL $24.25
- 52 Week High
- ELVN $30.03
- XPEL $48.58
- Technical
- Relative Strength Index (RSI)
- ELVN 55.53
- XPEL 51.28
- Support Level
- ELVN $18.53
- XPEL $35.83
- Resistance Level
- ELVN $24.11
- XPEL $37.78
- Average True Range (ATR)
- ELVN 1.96
- XPEL 1.03
- MACD
- ELVN 0.15
- XPEL -0.30
- Stochastic Oscillator
- ELVN 55.68
- XPEL 35.19
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.